# Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity

> **NCT04298515** · NA · UNKNOWN · sponsor: **Istanbul Medeniyet University** · enrollment: 180 (estimated)

## Conditions studied

- Type 2 Diabetes
- Insulin Resistance
- Obesity
- Nesfatin-1

## Interventions

- **DIAGNOSTIC_TEST:** Nesfatin-1

## Key facts

- **NCT ID:** NCT04298515
- **Lead sponsor:** Istanbul Medeniyet University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-02
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04298515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04298515, "Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04298515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*